Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Biomarkers & Precision Medicine
ScaiPod: The most comprehensive single-cell omics dataset in immuno-oncology
Drug Discovery & Development
ScaiVision AI platform: project workflow to facilitate drug development
Immuno-Oncology
Finding New Immunotherapy Targets for Solid Brain Tumour CAR Ts with RNAseq in Cancer-Specific Exons
The project has found over 150 target candidates for solid brain tumour therapies.
"World's First" IND Approval for Epstein-Barr mRNA Cancer Vaccine
Epstein-Barr virus has been highly linked to over ten forms of cancer. This wide range of malignant implications means an expanded variety of target indications for the vaccine.
Manufacturing & Bioprocessing
Implementing Process Analytical Technology into Cell and Gene Therapy Manufacturing
A recent study shows that a novel refractometry-based PAT system monitors metabolic activity during CGT production, revealing insights into optimising bioprocesses.
Immuno-Oncology
Patients Enter Clinic for Phase III mRNA Immunotherapy for High Risk Melanoma
The trial will test the world's first mRNA-based personalised immunotherapy for melanoma.
Stem Cell Therapy
In Conversation with Stephen Sullivan, COO of iPSirius
Cell & Gene 2024 Conference Producer Anya Chuykov met with Stephen Sullivan, COO of iPSirius, to discuss the advancements being made by iPSirius, and their unique proprietary technology working to treat aggressive forms of cancer.
Immunotherapy (Non-Oncology)
First Patient Dosed with NK Cell Therapy for the Treatment of an Autoimmune Disease, Lupus Nephritis
The NK cell therapy is being trialled in combination with monoclonal antibody therapy and hopes to induce B-cell depletion.
Peptide Chemistry
Sustainable Pharma: Celebrating Progress and Confronting Challenges on Earth Day
Earth Day marks a moment to reflect on the planet's health and our collective efforts to nurture it. To celebrate Earth Day, this article will examine the strides the pharmaceutical and biotechnology industry has made towards fostering sustainable and green practices alongside the challenges.
Antibody & Protein Engineering
Rapid Analytical Approach for Biologics Characterization Using Mass Photometry
On-demand webinar featuring Dr Racha Majed, Technical Sales Specialist, Refeyn